BR0017013A - Composições de antibiótico azalìdeo - Google Patents

Composições de antibiótico azalìdeo

Info

Publication number
BR0017013A
BR0017013A BR0017013-5A BR0017013A BR0017013A BR 0017013 A BR0017013 A BR 0017013A BR 0017013 A BR0017013 A BR 0017013A BR 0017013 A BR0017013 A BR 0017013A
Authority
BR
Brazil
Prior art keywords
antibiotic compositions
azaldehyde
compositions
antibiotic
solvents
Prior art date
Application number
BR0017013-5A
Other languages
English (en)
Other versions
BRPI0017013B1 (pt
BR0017013A2 (pt
Inventor
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22652702&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0017013(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0017013A publication Critical patent/BR0017013A/pt
Publication of BR0017013A2 publication Critical patent/BR0017013A2/pt
Publication of BRPI0017013B1 publication Critical patent/BRPI0017013B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"COMPOSIçõES DE ANTIBIóTICO AZALìDEO". São descritas composições antibióticas compreendendo uma mistura de equilíbrio de isómeros azalídeos, água e um ou mais ácidos, e métodos para a preparação de tais composições. As composições antibióticas podem ser vantajosamente estabilizadas por adição de um ou mais co-solventes miscíveis em água. Em uma modalidade preferida, o um ou mais co-solventes é propilenoglicol.
BRPI0017013-5A 2000-01-27 2000-11-30 Composição de antibiótico azalídeo e método para sua obtenção BRPI0017013B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17848100P 2000-01-27 2000-01-27
US60/178,481 2000-01-27
PCT/IB2000/001824 WO2001055158A1 (en) 2000-01-27 2000-11-30 Azalide antibiotic compositions

Publications (3)

Publication Number Publication Date
BR0017013A true BR0017013A (pt) 2002-10-22
BR0017013A2 BR0017013A2 (pt) 2010-07-13
BRPI0017013B1 BRPI0017013B1 (pt) 2015-07-14

Family

ID=22652702

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0017013-5A BRPI0017013B1 (pt) 2000-01-27 2000-11-30 Composição de antibiótico azalídeo e método para sua obtenção
BRPI0017013A BRPI0017013B8 (pt) 2000-01-27 2000-11-30 composição de antibiótico azalídeo e método para sua obtenção

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0017013A BRPI0017013B8 (pt) 2000-01-27 2000-11-30 composição de antibiótico azalídeo e método para sua obtenção

Country Status (21)

Country Link
US (2) US6514945B1 (pt)
EP (1) EP1250343B1 (pt)
JP (2) JP3893059B2 (pt)
AR (2) AR030045A1 (pt)
AT (1) ATE243703T1 (pt)
AU (1) AU779748C (pt)
BR (2) BRPI0017013B1 (pt)
CA (1) CA2398485C (pt)
CO (1) CO5251404A1 (pt)
DE (1) DE60003586T2 (pt)
DK (1) DK1250343T3 (pt)
ES (1) ES2199884T3 (pt)
MX (1) MXPA02007305A (pt)
NZ (1) NZ518665A (pt)
PA (1) PA8509801A1 (pt)
PE (1) PE20011050A1 (pt)
PT (1) PT1250343E (pt)
TN (1) TNSN01017A1 (pt)
TW (2) TWI318880B (pt)
WO (1) WO2001055158A1 (pt)
ZA (1) ZA200205958B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
ES2314724T3 (es) 2004-09-23 2009-03-16 Schering-Plough Ltd. Control de parasitos en animales mediante el uso de nuevos derivados de eter de trifluorometanosulfonanilida oxima.
CA2587495A1 (en) * 2004-11-19 2006-05-26 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
MX2007015729A (es) * 2005-06-09 2008-02-21 Schering Plough Ltd Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida.
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
US20080044455A1 (en) * 2006-08-21 2008-02-21 Chaim Welczer Tonsillitus Treatment
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
MX2009006282A (es) * 2006-12-13 2009-06-23 Schering Plough Ltd Profarmacos solubles en agua de florfenicol y sus analogos.
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
BRPI0810929B8 (pt) 2007-06-27 2022-12-06 Du Pont uso de um composto de fórmula 1
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
US8314252B2 (en) * 2008-07-30 2012-11-20 Intervet Inc. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
JP2013501063A (ja) 2009-08-05 2013-01-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー メソイオン性殺虫剤
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
AU2010279574A1 (en) 2009-08-05 2012-02-09 E. I. Du Pont De Nemours And Company Mesoionic pesticides
ES2566402T3 (es) 2010-05-27 2016-04-12 E. I. Du Pont De Nemours And Company Forma cristalina de 4-[5-[3-cloro-5-(trifluorometil)fenil]-4,5-dihidro-5-(trifluorometil)-3-isoxazolil]-N-[2-oxo-2-[(2,2,2-trifluoroetil)amino]etil]-1-naftalenocarboxamida
EP2588084B1 (en) 2010-07-01 2023-11-22 Elanco Tiergesundheit AG Antibiotic compositions comprising tulathromycin
US9212201B2 (en) * 2010-07-23 2015-12-15 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
BR112013032813A2 (pt) 2011-06-20 2016-08-16 Du Pont composto de fórmula, composição e método para o tratamento, controle, prevenção ou proteção dos animais contra a infecção por helmintos
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
EP2776667B1 (en) 2011-11-11 2022-03-02 ExxonMobil Upstream Research Company Method and system for reservoir surveillance utilizing clumped isotope and noble gas data
EP2776866B1 (en) 2011-11-11 2020-06-17 Exxonmobil Upstream Research Company Method for determining the location, size, and fluid composition of a subsurface hydrocarbon accumulation
RU2014126367A (ru) 2011-11-28 2016-01-27 Е.И.Дюпон Де Немур Энд Компани Производные n-(4-хинолинметил)сульфонамидов и их применение в качестве антигельминтных средств
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
US9044508B2 (en) 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
AU2014248014B2 (en) 2013-04-04 2018-11-08 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
EP3114505B1 (en) 2014-03-07 2022-07-20 ExxonMobil Upstream Research Company Exploration method and system for detection of hydrocarbons from the water column
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
CA2963815A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof
ES2858585T3 (es) * 2016-01-18 2021-09-30 Zhejiang Hisun Pharm Co Ltd Método y producto intermedio para preparar tulatromicina
KR20210123288A (ko) * 2018-11-19 2021-10-13 지카니 테라퓨틱스, 인크. C11-환식 치환된 13-원 마크롤라이드 및 이의 용도
US20230129438A1 (en) 2020-03-12 2023-04-27 Zoetis Services Llc Immunomodulating imine-oxazoline azalides
WO2023038852A1 (en) 2021-09-07 2023-03-16 Zoetis Services Llc Immunomodulating azalides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6128174A (en) 1997-08-29 2000-10-03 Stereotaxis, Inc. Method and apparatus for rapidly changing a magnetic field produced by electromagnets
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
JP3897983B2 (ja) * 1999-05-18 2007-03-28 ファイザー・プロダクツ・インク マクロライド系抗生物質の新規結晶

Also Published As

Publication number Publication date
EP1250343B1 (en) 2003-06-25
US6514945B1 (en) 2003-02-04
TWI331527B (en) 2010-10-11
US20030073825A1 (en) 2003-04-17
CO5251404A1 (es) 2003-02-28
CA2398485C (en) 2008-01-29
PA8509801A1 (es) 2002-02-21
JP3893059B2 (ja) 2007-03-14
ATE243703T1 (de) 2003-07-15
JP2006282676A (ja) 2006-10-19
NZ518665A (en) 2005-02-25
JP2004500384A (ja) 2004-01-08
AR030045A1 (es) 2003-08-13
DE60003586D1 (de) 2003-07-31
ZA200205958B (en) 2003-09-29
DE60003586T2 (de) 2004-01-08
TW201006476A (en) 2010-02-16
PT1250343E (pt) 2003-11-28
WO2001055158A1 (en) 2001-08-02
BRPI0017013B8 (pt) 2022-11-16
BRPI0017013B1 (pt) 2015-07-14
TNSN01017A1 (fr) 2005-11-10
US20030013860A1 (en) 2003-01-16
AR039387A2 (es) 2005-02-16
AU1722801A (en) 2001-08-07
ES2199884T3 (es) 2004-03-01
TWI318880B (en) 2010-01-01
AU779748B2 (en) 2005-02-10
CA2398485A1 (en) 2001-08-02
AU779748C (en) 2005-12-08
BR0017013A2 (pt) 2010-07-13
DK1250343T3 (da) 2003-09-22
MXPA02007305A (es) 2002-11-29
US6667393B2 (en) 2003-12-23
PE20011050A1 (es) 2001-10-19
EP1250343A1 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
BR0017013A (pt) Composições de antibiótico azalìdeo
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
BR0211390A (pt) Tratamento de infecções da unha com no
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
ATE255589T1 (de) Kristallin form i von clarithromycin
ECSP003682A (es) Compuestos para el tratamiento de la isquemia
AR024138A1 (es) Inhibidores de la proliferacion celular
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ATE275404T1 (de) Isomalt als wirkstoff enthaltendes erkältungsmittel
ES2189182T3 (es) Empleo de alcoholes como aditivos para revoques y/o morteros.
DE3762871D1 (de) Treibmittel fuer schaeumbare siloxanzusammensetzungen.
SE9801494D0 (sv) Novel use
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
WO2003011266A3 (en) Azalide antibiotic compositions
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
DE69208016D1 (de) Inhibierte 141b
ATE259886T1 (de) Ledergerben
DE69431662D1 (de) Stabilisierte tablettenformulierung
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
BR0210731A (pt) Uso de ácidos fluoralcanossulfÈnicos para estabilizar plásticos orgânicos contendo halogênio

Legal Events

Date Code Title Description
B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 1659 DE 22/10/2002.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 30/11/2020

B22E Other requirements [chapter 22.5 patent gazette]

Free format text: FORMULADA EXIGENCIA PARA ADEQUACAO OU CUMPRIMENTO DE DISPOSICOES LEGAIS NO PRAZO DE 60 (SESSENTA) DIAS DESTA DATA.

B16B Notification of grant cancelled [chapter 16.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 16.3 NA RPI NO 2629 DE 25/05/2021 POR TER SIDO INDEVIDA.

B21I Extinguishment of a patent or of a certificate of addition of invention: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 21.1 NA RPI NO 2630 DE 01/06/2021 POR TER SIDO INDEVIDA.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: RETIFICACAO REF. RPI 2323, DE 14/07/2015. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS, PARA MATERIA RELATIVA A PRODUTOS E PROCESSOS COM APLICACAO VETERINARIA. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI NO 52402.011451/2022-67 ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5071020-25.2022.4.02.5101/RJ SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: OURO FINO SAUDE ANIMAL LTDA REU(S): ZOETIS SERVICES LLC E INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: RETIFICACAO REF. RPI 2323, DE 14/07/2015. PRAZO DE VALIDADE: 10 ANOS CONTADOS A PARTIR DE 14/07/2015, OBSERVADAS AS CONDICOES LEGAIS, PARA MATERIA RELATIVA A PRODUTOS E PROCESSOS COM APLICACAO VETERINARIA. PATENTE CONCEDIDA CONFORME A ADI 5.529/DF, COM APOSTILAMENTO DO PRAZO DE VALIDADE DA PROTECAO DA MATERIA RELATIVA A PRODUTOS E PROCESSOS FARMACEUTICOS E EQUIPAMENTOS E/OU MATERIAIS DE USO EM SAUDE, PARA APLICACAO EM HUMANOS.